Fabiana Ostronoff, MD¹, Rhonda E. Ries, MA^1*, Robert B. Gerbing, MA^2*, Marco A Marra, PhD³, Ma Yussanne^4*, William Long, PhD^5*, Stuart Zong^5*, Karen Mungall, PhD^5*, Andrew Andrew^4*, Daniela S. Gerhard, PhD^6*, Malcolm A. Smith, MD, PhD⁷, Gesuwan Patee^8*, Tanja M. Davidsen, PhD^6*, Leandro C. Hermida^6*, Jason E. Farrar, M.D.⁹, Jaime Guidry Auvil^8*, Susana C. Raimondi, PhD¹⁰, Betsy A. Hirsch, PhD^2*, E. Anders Kolb, MD¹¹, Alan S. Gamis, MD, MPH¹², Todd A. Alonzo, PhD¹³ and Soheil Meshinchi, MD, PhD¹

¹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
²Children's Oncology Group, Monrovia, CA
³Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
⁴Genome Sciences Center, British Columbia Cancer Agency, Vancouver, Canada
⁵Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
⁶Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
⁷Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
⁸National Cancer Institute, Bethesda
⁹Department of Pediatics/Hematology Oncology Section, University of Arkansas for Medical Sciences, Little Rock, AR
¹⁰Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
¹¹Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
¹²Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
¹³Keck School of Medicine, University of Southern California, Los Angeles, CA

Diana Chin^1*, Matthew A. Kutny, MD², Jonathan Grim, MD, PhD^3*, Robert B. Gerbing, MA^4*, Kristen Miller, BS^1*, Jason E. Farrar, M.D.⁵, Jaime M. Guidry Auvil, PhD^6*, Malcolm A. Smith, MD, PhD⁷, Daniela S. Gerhard, PhD^6*, Tanja M. Davidsen, PhD^6*, Patee Gesuwan^6*, Leandro C. Hermida^6*, Marco A Marra, PhD⁸, Andrew J. Mungall, PhD⁹, Richard Moore, PhD^8*, William Long, PhD^9*, Yussanne Ma, PhD^9*, Stuart Zong^9*, E. Anders Kolb, MD¹⁰, Alan S. Gamis, MD, MPH¹¹, Todd A. Alonzo, PhD¹² and Soheil Meshinchi, MD, PhD¹

¹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
²Department of Pediatrics, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
³VA Puget Sound Health Care Systems, Seattle, WA
⁴Children's Oncology Group, Monrovia, CA
⁵Department of Pediatics/Hematology Oncology Section, University of Arkansas for Medical Sciences, Little Rock, AR
⁶Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
⁷Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
⁸Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
⁹Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
¹⁰Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
¹¹Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
¹²Keck School of Medicine, University of Southern California, Los Angeles, CA

Jasmijn de Rooij, MD^1*, Cristyn Branstetter, MD², Jing Ma, PhD^3*, Yongjin Li, PhD^4*, Jinjun Cheng, MD, PhD^3*, Cary Koss, BS^2*, John Easton, PhD^5*, Lonneke Jantine Verboon, BSc^1*, Heather L. Mulder, BS^5*, Michael Rusch, BA^4*, Joshua Yew Suang Lim, BS^6*, Katarina Reinhardt, PhD^7*, Allen Eng Juh Yeoh, MD⁶, Lee-Yung Shih, MD⁸, Der-Cherng Liang, MD⁹, Stephanie Halene, MD¹⁰, Diane S Krause, MD, PhD¹¹, Jinghui Zhang, PhD^4*, James R. Downing, MD³, Franco Locatelli, MD, PhD¹², Dirk Reinhardt, MD⁷, Marry M van den Heuvel-Eibrink, MD, PhD^13,14*, Maarten Forenerod, PhD^1*, C. Michel Zwaan, MD, PhD^1,14 and Tanja A. Gruber, MD, PhD^2,3

¹Department of Pediatric Oncology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, Netherlands
²Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
³Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
⁴Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN
⁵Pediatric Cancer Genome Project, St. Jude Children's Research Hospital, Memphis, TN
⁶Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
⁷Department of Paediatric Oncology, University of Duisburg-Essen, Essen, Germany
⁸Department of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, College of Medicine Chang Gung University, Taipei, Taiwan
⁹Mackay Memorial Hospital, Taipei, Taiwan
¹⁰Section of Hematology, Department of Internal Medicine and Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT
¹¹Laboratory Medicine, Yale University School of Medicine, New Haven, CT
¹²University of Pavia, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
¹³Department of Pediatric Oncology, Princess Maxima Center for Paediatric Oncology, Utrecht, Netherlands
¹⁴Dutch Childhood Oncology Group, Hague, Netherlands

Oussama Abla, MD¹, Raul C. Ribeiro, MD², Anna Maria Testi, MD^3*, Pau Montesinos Fernández, MD^4*, Ursula Creutzig, MD⁵, Lillian Sung, MD, PhD⁶, Giancarlo Di Giuseppe, BSc^1*, Derek Stephens, MSc^1*, Henrik Hasle, MD, PhD⁷, Gertjan J.L. Kaspers, MD, PhD⁸, Luciano Dalla-Pozza, MB BS FRACP⁹, Alvaro Lassaletta, MD^10*, Martin S. Tallman, MD¹¹, Franco Locatelli, MD¹², Dirk Reinhardt, MD¹³, Johann Hitzler, MD, FRCP (C), FAAP¹ and Miguel A. Sanz, MD, PhD⁴

¹Division of Haematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
²St. Jude Children's Research Hospital, Memphis, TN
³Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy
⁴Department of Medicine, University of Valencia, Hospital Universitario y Politécnico La Fe, Valencia, Spain
⁵Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany
⁶Population Health Sciences, Research Institute, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
⁷Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark
⁸Dutch Childhood Oncology Group, The Hague, Netherlands
⁹Department of Oncology, The Children's Hospital at Westmead, Westmead, Australia
¹⁰Pediatric Hematology-Oncology Department, Hospital Niño Jesús, Madrid, Spain
¹¹Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY
¹²Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
¹³AML-BFM Study Group, Pediatric Hematology/Oncology, University Children’s Hospital Essen, Essen, Germany

Yi Zhou, MD, PhD^1*, Daisuke Araki, MD^2*, Megan Othus, PhD^3*, Jerald P. Radich, MD^4,5, Anna B. Halpern, MD⁶, Marco Mielcarek, MD^4,7, Elihu H. Estey, MD^4,8*, Brent L. Wood, MD, PhD¹, Frederick R. Appelbaum, MD^3,9 and Roland B. Walter, MD, PhD, MS^4,10,11

¹Department of Laboratory Medicine/Division of Hematopathology, University of Washington, Seattle, WA
²Department of Medicine, University of Washington, Seattle, WA
³Fred Hutchinson Cancer Research Center, Seattle, WA
⁴Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁵Department of Medicine/Division of Medical Oncology, University of Washington, Seattle, WA
⁶Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
⁷Department of Medicine/ Division of Medical Oncology, University of Washington, Seattle, WA
⁸Division of Hematology, University of Washington, Seattle, WA
⁹University of Washington, Seattle, WA
¹⁰Department of Medicine/Division of Hematology, University of Washington, Seattle, WA
¹¹Department of Epidemiology, University of Washington, Seattle, WA

Julia Elizabeth Maxson, PhD¹, Rhonda Ries, MA^1*, Yi-Cheng Wang, MS^2*, Robert B. Gerbing, MA^2*, E. Anders Kolb, MD³, Sarah L Thompson^1*, Jaime M. Guidry Auvil, PhD^4*, Marco A Marra, PhD⁵, Yussanne Ma, PhD^6*, Stuart Zong^6*, Andrew J. Mungall, PhD⁶, Richard Moore, PhD^7*, William Long, PhD^6*, Patee Gesuwan^4*, Tanja M. Davidsen, PhD^4*, Leandro C. Hermida^4*, Jason E. Farrar, M.D.⁸, Jerald P. Radich, MD¹, Malcolm A. Smith, MD, PhD⁹, Daniela S. Gerhard, PhD^4*, Alan S. Gamis, MD, MPH^2,10, Todd A. Alonzo, PhD^2,11 and Soheil Meshinchi, MD, PhD^1,2

¹Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
²Children's Oncology Group, Monrovia, CA
³Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
⁴Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
⁵Canada’s Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
⁶Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
⁷Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
⁸Department of Pediatics/Hematology Oncology Section, University of Arkansas for Medical Sciences, Little Rock, AR
⁹Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
¹⁰Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
¹¹Keck School of Medicine, University of Southern California, Los Angeles, CA